Resolving Histological Inflammation in Ulcerative Colitis With Mirikizumab in the LUCENT Induction and Maintenance Trial Programmes.

Magro F, Pai RK, Kobayashi T, Jairath V, Rieder F, Redondo I, Lissoos T, Morris N, Shan M, Park M, Peyrin-Biroulet L

Open source

DOI
10.1093/ecco-jcc/jjad050
Published
2023 Oct 20
Container
Journal of Crohn's & colitis
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ecco-jcc/jjad050,
  title = {Resolving Histological Inflammation in Ulcerative Colitis With Mirikizumab in the LUCENT Induction and Maintenance Trial Programmes.},
  author = {Magro F and Pai RK and Kobayashi T and Jairath V and Rieder F and Redondo I and Lissoos T and Morris N and Shan M and Park M and Peyrin-Biroulet L},
  year = {2023},
  journal = {Journal of Crohn's \& colitis},
  doi = {10.1093/ecco-jcc/jjad050},
  url = {https://doi.org/10.1093/ecco-jcc/jjad050}
}

RIS

TY  - JOUR
TI  - Resolving Histological Inflammation in Ulcerative Colitis With Mirikizumab in the LUCENT Induction and Maintenance Trial Programmes.
AU  - Magro F
AU  - Pai RK
AU  - Kobayashi T
AU  - Jairath V
AU  - Rieder F
AU  - Redondo I
AU  - Lissoos T
AU  - Morris N
AU  - Shan M
AU  - Park M
AU  - Peyrin-Biroulet L
PY  - 2023
JO  - Journal of Crohn's & colitis
DO  - 10.1093/ecco-jcc/jjad050
UR  - https://doi.org/10.1093/ecco-jcc/jjad050
ER  - 

APA

F, M., RK, P., T, K., V, J., F, R., I, R., T, L., N, M., M, S., M, P., & L, P. (2023). Resolving Histological Inflammation in Ulcerative Colitis With Mirikizumab in the LUCENT Induction and Maintenance Trial Programmes.. Journal of Crohn's & colitis. https://doi.org/10.1093/ecco-jcc/jjad050

Source records